New schizophrenia drug MK-8189 passes early safety check in 63 patients
NCT ID NCT04506905
First seen Apr 29, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This early-stage study tested the safety and how the body handles a new drug called MK-8189 (elpipodect) in 63 people. It included younger adults with schizophrenia and older adults with or without schizophrenia. The main goal was to check for side effects and see how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Collaborative NeuroScience Network ( Site 0008)
Long Beach, California, 90806, United States
-
Hassman Research Institute ( Site 0007)
Berlin, New Jersey, 08009, United States
-
Parexel ( Site 0004)
Glendale, California, 91206, United States
-
RCA at Fort Lauderdale Behavioral Health Center ( Site 0006)
Oakland Park, Florida, 33334, United States
-
Velocity Clinical Research, Hallandale Beach ( Site 0001)
Hallandale, Florida, 33009, United States
-
Woodland Research Northwest, LLC ( Site 0002)
Rogers, Arkansas, 72758-6442, United States
Conditions
Explore the condition pages connected to this study.